Treatment for metastatic prostate cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Prostate Cell Line, Tumor Neoplastic Cells, Circulating Tumor Cells, Cultured Bone and Bones Osteoclasts Osteoblasts Epithelial Cells Neoplastic Stem Cells Chromosomes, Human, Pair 8 Seminal Vesicles Rectum Stromal Cells

Organisms4

Mice, Nude Mice, SCID Mice, Transgenic Mice, Inbred BALB C

Diseases35

Prostatic Neoplasms Neoplasm Metastasis Bone Neoplasms Neoplasms, Hormone-Dependent Adenocarcinoma Disease Progression Prostatic Neoplasms, Castration-Resistant Prostatic Hyperplasia Neoplastic Cells, Circulating Neoplasm Invasiveness Prostatic Intraepithelial Neoplasia Neoplasm Recurrence, Local Cell Transformation, Neoplastic Carcinoma Osteolysis Soft Tissue Neoplasms Lymphatic Metastasis Genetic Predisposition to Disease Lung Neoplasms Breast Neoplasms Disease Models, Animal Neoplasms Pain Ovarian Neoplasms Colonic Neoplasms Stomach Neoplasms Prostatic Diseases Prostatitis Pancreatic Neoplasms Neovascularization, Pathologic Urinary Bladder Neoplasms Colorectal Neoplasms Uterine Cervical Neoplasms Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung

Chemicals and Drugs75

Prostate-Specific Antigen Androgen Antagonists Receptors, Androgen Androgens Antineoplastic Agents, Hormonal Flutamide Tosyl Compounds Estramustine Tumor Markers, Biological Strontium Radioisotopes Radium Anilides Taxoids Antineoplastic Agents Androstenols Leuprolide Glutamate Carboxypeptidase II Neoplasm Proteins Suramin Diphosphonates Gonadotropin-Releasing Hormone Polycomb Repressive Complex 2 RNA, Messenger Cancer Vaccines Radioisotopes PTEN Phosphohydrolase RNA, Small Interfering Nitriles Tissue Extracts Indium Radioisotopes Testosterone Mitoxantrone Androgen Receptor Antagonists Proto-Oncogene Proteins c-akt Radiopharmaceuticals Transcription Factors Dihydrotestosterone DNA Primers Finasteride DNA, Neoplasm Antibodies, Monoclonal Prednisone Metribolone DNA-Binding Proteins Antigens, Neoplasm Anticarcinogenic Agents 5-alpha Reductase Inhibitors Testosterone Congeners Proto-Oncogene Proteins Antineoplastic Agents, Phytogenic 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Azasteroids Phenylthiohydantoin Yttrium Radioisotopes Racemases and Epimerases RNA, Neoplasm Tumor Suppressor Protein p53 Cholestenone 5 alpha-Reductase MicroRNAs Imidazoles Tumor Suppressor Proteins Goserelin Receptor, erbB-2 Glutathione S-Transferase pi Receptors, Estrogen Enzyme Inhibitors Prostatic Secretory Proteins Androgen-Binding Protein Proto-Oncogene Proteins c-bcl-2 Kallikreins Steroid 17-alpha-Hydroxylase Paclitaxel Oncogene Proteins, Fusion Insulin-Like Growth Factor Binding Protein 3 Carotenoids

Analytical, Diagnostic and Therapeutic Techniques and Equipment77

Orchiectomy Prostatectomy Prognosis Immunohistochemistry Neoplasm Transplantation Transplantation, Heterologous Xenograft Model Antitumor Assays Treatment Outcome Reverse Transcriptase Polymerase Chain Reaction Neoplasm Staging Survival Analysis Molecular Targeted Therapy Castration Early Detection of Cancer Clinical Trials, Phase III as Topic Antineoplastic Combined Chemotherapy Protocols Tissue Array Analysis Gene Expression Profiling Blotting, Western Sensitivity and Specificity Radioimmunotherapy Disease-Free Survival Transfection Oligonucleotide Array Sequence Analysis Survival Rate Neoplasm Grading Combined Modality Therapy Predictive Value of Tests In Situ Hybridization, Fluorescence Immunotherapy Palliative Care Kaplan-Meier Estimate Digital Rectal Examination Risk Factors Drug Administration Schedule Follow-Up Studies Disease Models, Animal Retrospective Studies Positron-Emission Tomography Case-Control Studies Flow Cytometry Models, Biological Transurethral Resection of Prostate Risk Cohort Studies Prospective Studies Biopsy Risk Assessment Polymerase Chain Reaction Biopsy, Needle Randomized Controlled Trials as Topic Odds Ratio Brachytherapy Incidence Tumor Burden SEER Program Multivariate Analysis Registries Radiotherapy Nomograms Proportional Hazards Models Drug Screening Assays, Antitumor Logistic Models Radiotherapy Dosage Radiotherapy, Conformal Reproducibility of Results Questionnaires Mass Screening Gene Knockdown Techniques Confidence Intervals Clinical Trials as Topic Tomography, X-Ray Computed Immunoenzyme Techniques Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted ROC Curve Chemotherapy, Adjuvant

Psychiatry and Psychology2

Phenomena and Processes45

Gene Expression Regulation, Neoplastic Cell Proliferation Drug Resistance, Neoplasm Apoptosis Cell Movement Signal Transduction Sensitivity and Specificity Gene Silencing Time Factors Up-Regulation Transfection Cell Survival Cell Division Osteolysis Dose-Response Relationship, Drug Genetic Predisposition to Disease Down-Regulation Base Sequence Pain Risk Cell Growth Processes Genotype Odds Ratio DNA Methylation Promoter Regions, Genetic Epithelial-Mesenchymal Transition Cell Cycle Polymorphism, Genetic Mutation Nomograms Gene Fusion Phenotype Genes, Tumor Suppressor RNA Interference Chromosomes, Human, Pair 8 Cell Adhesion Gene Expression Phosphorylation Diet Polymorphism, Single Nucleotide Alleles Transcription, Genetic Genes, Neoplasm Germ-Line Mutation Drug Synergism

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science10

Survival Rate Base Sequence Molecular Sequence Data Incidence SEER Program Registries Radiotherapy, Conformal Questionnaires Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted

Named Groups3

European Continental Ancestry Group African Americans Survivors

Health Care35

Treatment Outcome Survival Analysis Clinical Trials, Phase III as Topic Sensitivity and Specificity Disease-Free Survival Survival Rate Predictive Value of Tests Palliative Care Kaplan-Meier Estimate Risk Factors Watchful Waiting Follow-Up Studies Retrospective Studies Case-Control Studies Risk Cohort Studies Prospective Studies Risk Assessment Randomized Controlled Trials as Topic Odds Ratio Incidence National Cancer Institute (U.S.)SEER Program Multivariate Analysis Age Factors Registries Nomograms Proportional Hazards Models Logistic Models Reproducibility of Results Questionnaires Mass Screening Confidence Intervals Clinical Trials as Topic ROC Curve

Geographicals3

United States Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Prostatic Neoplasms Prostate Prostate-Specific Antigen Neoplasm Metastasis Orchiectomy Bone Neoplasms Androgen Antagonists Receptors, Androgen Cell Line, Tumor Androgens Antineoplastic Agents, Hormonal Neoplasms, Hormone-Dependent Adenocarcinoma Flutamide Tosyl Compounds Prostatectomy Disease Progression Gene Expression Regulation, Neoplastic Estramustine Tumor Markers, Biological Strontium Radioisotopes Prostatic Neoplasms, Castration-Resistant Prostatic Hyperplasia Radium Anilides Neoplastic Cells, Circulating Taxoids Mice, Nude Neoplasm Invasiveness Antineoplastic Agents Androstenols Prognosis Tumor Cells, Cultured Immunohistochemistry Neoplasm Transplantation Cell Proliferation Transplantation, Heterologous Xenograft Model Antitumor Assays Treatment Outcome Leuprolide Reverse Transcriptase Polymerase Chain Reaction Mice, SCID Neoplasm Staging Survival Analysis Glutamate Carboxypeptidase II Neoplasm Proteins Molecular Targeted Therapy Castration Drug Resistance, Neoplasm Apoptosis Suramin Diphosphonates Gonadotropin-Releasing Hormone Polycomb Repressive Complex 2 Cell Movement RNA, Messenger Early Detection of Cancer Cancer Vaccines Clinical Trials, Phase III as Topic Radioisotopes Signal Transduction Antineoplastic Combined Chemotherapy Protocols Tissue Array Analysis Gene Expression Profiling PTEN Phosphohydrolase Blotting, Western Prostatic Intraepithelial Neoplasia Sensitivity and Specificity RNA, Small Interfering Nitriles Tissue Extracts Radioimmunotherapy Disease-Free Survival Indium Radioisotopes Neoplasm Recurrence, Local Gene Silencing Time Factors Up-Regulation Transfection Cell Survival Oligonucleotide Array Sequence Analysis Survival Rate Testosterone Neoplasm Grading Cell Transformation, Neoplastic Carcinoma Cell Division Combined Modality Therapy Predictive Value of Tests Osteolysis In Situ Hybridization, Fluorescence Soft Tissue Neoplasms Immunotherapy Mitoxantrone Lymphatic Metastasis Dose-Response Relationship, Drug Genetic Predisposition to Disease Palliative Care Androgen Receptor Antagonists Kaplan-Meier Estimate

No FAQ available that match "treatment for metastatic prostate cancer"